Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection


Creative Commons License

Pepeler M. S. , YILDIZ Ş. , YEGİN Z. A. , ÖZKURT Z. N. , GÜZEL TUNÇCAN Ö. , ERBAŞ G. , ...Daha Fazla

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.12, sa.9, ss.799-805, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 12 Konu: 9
  • Basım Tarihi: 2018
  • Doi Numarası: 10.3855/jidc.9961
  • Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Sayfa Sayıları: ss.799-805

Özet

Introduction: Invasive fungal infection (IFI) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history of IFI is not an absolute contraindication for allo-HSCT, particularly in the era of secondary antifungal prophylaxis (SAP). Prompt diagnosis and therapy are essential for HSCT outcome.